Provided by Tiger Trade Technology Pte. Ltd.

ARS PHARMACEUTICALS INC

7.94
-0.2900-3.52%
Post-market: 7.91-0.0300-0.38%19:19 EDT
Volume:2.49M
Turnover:20.00M
Market Cap:784.86M
PE:-3.96
High:8.29
Open:8.23
Low:7.91
Close:8.23
52wk High:18.90
52wk Low:6.66
Shares:98.85M
Float Shares:55.27M
Volume Ratio:1.11
T/O Rate:4.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0044
EPS(LYR):-1.7400
ROE:-136.40%
ROA:-41.15%
PB:12.80
PE(LYR):-4.56

Loading ...

Aug 13, 2025

Major Issues Report

Form 8-K - Current report
Jul 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 26, 2025

Major Issues Report

Form 8-K - Current report
Jun 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 14, 2025

Major Issues Report

Form 8-K - Current report
May 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2025

Major Issues Report

Form 8-K - Current report
Apr 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 20, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 20, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 20, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities